Stock listing
NASDAQ:APTX Aptinyx Inc Stock
Follow Aptinyx Inc into a list and get an email when it puts out news.
Delisted NASDAQ:APTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:APTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Aptinyx Inc on 6ix
- Calls
- 8 calls with a replay · 8 with a transcript · latest Nov 8, 2022
- Decks
- 6 decks · latest Feb 9, 2022
Events
| Call | When | Status |
|---|---|---|
| Aptinyx (APTX) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q1 2022 Earnings Call | Thu, May 12, 2022 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q4 2021 Earnings Call | Wed, Mar 23, 2022 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q2 2021 Earnings Call | Tue, Aug 10, 2021 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q1 2021 Earnings Call | Thu, May 13, 2021 · 5:00 PM ET | Replay |
| Aptinyx (APTX) Q4 2020 Earnings Call | Wed, Mar 24, 2021 · 5:00 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (February 2022) | Technical | 63 slides | Feb 9, 2022 |
| Investor Presentation (June 2021) | Investor deck | 57 slides | Jun 15, 2021 |
| Investor Presentation (June 2021) | Investor deck | 34 slides | Jun 15, 2021 |
| Technical Presentation (October 2020) | Technical | 24 slides | Oct 20, 2020 |
| Investor Presentation (August 2020) | Investor deck | 43 slides | Aug 5, 2020 |
| Investor Presentation (March 2019) | Investor deck | 16 slides | Mar 13, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Director · Jun 20, 2018 – Mar 31, 2020 · Past |
| Robert J. Hombach Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Henry Schein, Inc. (Director · Since at least Jan 29, 2025); Embecta Corp. (Director · Since at least Mar 20, 2022); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past); Baxalta Inc (EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past) | Director · Jun 20, 2018 – May 26, 2022 · Past |
| Henry Gosebruch Other companies: ANI Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2026); Neumora Therapeutics, Inc. (President & CEO, Director · Sep 14, 2023 – Feb 14, 2024 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); AbbVie Inc. (EVP, Chief Strategy Officer · Oct 30, 2017 – May 16, 2022 · Past) | Director · May 6, 2019 – May 26, 2022 · Past |
| Andrew Kidd | PRESIDENT AND CEO, Director · Jan 3, 2023 – Jan 3, 2023 · Past |
Log in to ask 6ix AI your own questions about Aptinyx Inc.